NEW
Stock Screener with Intrinsic Value
Abbott Laboratories (ABT)
Last Price$128.50.4%
Market Cap$222.8B
WACC
7.4%
Cost of Equity
7.9%
Cost of Debt
0.8%
Debt to Equity
6.7%
Beta
0.9
Stock quality
7/10
Good
ABT WACC
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
ABT Cost of Equity
Crunching data... Almost there!
ABT vs Peer Set: Discount Rate Comparison
WACC
Cost of Equity
General
Discount rate
financials
Company name
Revenue growth
EPS growth
Net Income margin
Abbott LaboratoriesABT
7.4%
(8.1%)
(16.2%)
14.3%
Median Peer Set
8.3%
8.8%
48.8%
11.8%
Align Technology, Inc.ALGN
11.4%
3.4%
26.0%
11.5%
Edwards Lifesciences CorporationEW
9.5%
11.6%
(6.1%)
23.4%
Insulet CorporationPODD
9.5%
30.0%
4,364.6%
12.2%
DexCom, Inc.DXCM
9.2%
24.5%
63.6%
14.9%
STERIS plcSTE
8.5%
3.6%
257.9%
7.4%
Koninklijke Philips N.V.PHG
8.2%
4.6%
(72.7%)
(2.6%)
Stryker CorporationSYK
8.1%
11.1%
33.9%
15.4%
Boston Scientific CorporationBSX
7.7%
12.3%
140.0%
11.2%
Medtronic plcMDT
7.6%
3.6%
(2.1%)
11.4%
Zimmer Biomet Holdings, Inc.ZBH
7.3%
6.5%
253.2%
13.8%
Explore more intrinsic value tools hub for ABT
Peter Lynch Fair Value
Margin of safety
Reverse DCF
Relative Value
DCF value calculator
Ben Graham Fair Value
Intrinsic Value
Peter Lynch charts
Earnings growth model
Earnings Power Value
Loved by
investors
worldwide
investors
worldwide
10K+
Investors
use our platform
#1
Top value investing hub
with all necessary tools
1K+
Experienced investors
in our community
4.9
Average rating across
all rating platforms
FAQ
What is Abbott Laboratories's discount rate as of Feb 03, 2025?
As of Feb 03, 2025, Abbott Laboratories's discount rate is 7.42%. This rate is determined based on the weighted average cost of capital (WACC) and the cost of equity, factoring in Abbott Laboratories's capital structure and risk profile.
What is Abbott Laboratories's weighted average cost of capital (WACC)?
Abbott Laboratories's WACC as of Feb 03, 2025, is 7.42%. This value is calculated by blending the cost of debt and cost of equity, reflecting the company’s overall cost of financing its operations.
What is Abbott Laboratories's cost of equity?
Abbott Laboratories's cost of equity is 7.9%, as of Feb 03, 2025. This is the return that shareholders expect based on the stock's risk level and market conditions, used to calculate the discount rate for valuing future cash flows.